University of Illinois at Chicago
Announcement of an Exempt Purchase
Vendor: Baxalta US, Inc., Bannockburn, IL
Amount: An estimated $900,000
An estimated start date of 4/15/2019 through 6/30/2020
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Friday, April 12, 2019
The University awarded a contract for Gammagard Immune Globulin.
Gammagard Immune Globulin is used to increase antibodies in the blood to fight infection or prevent an illness and infection. This is needed for patients of UI Health, including but not limited to, Hematology, Oncology and Fertility.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) The discontinuation of Flebogamma Immune Globulin by Grifols is creating a market shortage. We need to purchase Gammagard Immune Globulin to make up the difference. We use Immune Globilin for patients of UI Health, including but not limited to, Hemnatology, Oncology and Fertility. This is a very important treatment at UI Health.
For additional information, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.